My Cart

Glycoprotein D (HSV-1)

Glycoprotein D (HSV-1) Overview

English NameEnvelope glycoprotein DApproved Drugs0
Drugs in Clinical Trials1Target Synonym
Highest Development StagePhase 2 Clinical
English NameEnvelope glycoprotein D
Target Synonym
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

Product Inquiry

Glycoprotein D (HSV-1) Background

Herpesvirus infections are widely spread throughout the world population. Herpes simplex virus (HSV) belongs to the α-herpesvirus subfamily. There are two main types of HSV, HSV-1 and HSV-2, which infect humans. HSV-2 mainly causes genital lesions, whereas HSV-1 is involved in both oral and genital infections. Glycoprotein D (gD) is a structural component of the herpes simplex virus type 1 (HSV-1) envelope which is essential for virus entry and fusion with host cells. gD plays an important role by binding to the host receptors such as herpes virus entry mediator (HVEM) and nectin-1, a member of the immunoglobulin (Ig)-like cell adhesion molecules.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UB-621UB-621Phase 2 ClinicalUnited Biopharma IncHerpes Simplex; Herpes Genitalis
Details
  • Overview
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland